Valuation (47%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -1.70 | 31.19 |
PEG Ratio (TTM) | 0.00 | 10.50 |
P/S Ratio (TTM) | 4.25 | 5.80 |
P/B Ratio (TTM) | 0.37 | 4.76 |
P/FCF Ratio (TTM) | 11.02 | 18.59 |
Price to 5YR AVG Earnings Ratio | N/A | 29.55 |
Price to 5YR AVG FCF Ratio | N/A | 41.43 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -18.27% | 6.05% |
ROE (TTM) | -28.60% | 9.65% |
Net Profit Margin (TTM) | -39.91% | 13.99% |
ROIC 5YR AVG | N/A | 18.94% |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -1,332.74% | N/A | N/A |
Revenue | -68.92% | N/A | N/A |
Net Income | -469.88% | N/A | N/A |
Cash Flow | 49.92% | N/A | N/A |
Health (74%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 14.86 | 3.56 |
Quick Ratio (TTM) | 14.86 | 3.02 |
D/E Ratio (TTM) | 0.06 | 1.30 |
Interest Coverage (TTM) | -16.39 | 1.47 |
Piotroski F-Score | 8 | 6 |
Altman Z-Score | 7.15 | 17.43 |
LTL to 5YR AVG FCF | N/A | 1.43 |
Shares Outstanding Growth 5YR AVG | N/A | -0.45% |